TIME convened the first-ever TIME100 Health Leadership Forum to bring together individuals driving innovation and creating equitable initiatives within the health sector.

Uché Blackstock, Adrelia Allen, and Ai-jen Poo gathered at the TIME100 Health Leadership Forum in New York City on Oct. 22 to ...

"It is integrated into everything that we do," says Merck's chief information and digital officer Dave Williams.

Zacks Research lowered their Q3 2024 earnings estimates for Merck & Co., Inc. in a report issued on Monday, October 21st.

Empowering young women with the confidence to excel in their education is key to inspiring the next generation' ...

Immutep (ASX:IMM) has made significant progress over the past year with its lead immunotherapy candidate, eftilagimod alpha ...

Monty Williams has taken over the head coaching position at TMI Episcopal, his two sons' San Antonio high school.

We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates ...

Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...

Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer aft ...

Standigm uses Synthia Retrosynthesis Software from Merck KGaA, Darmstadt, Germany, to accelerate its drug design and synthesis processes driving advancements in pharmaceutical development. Standigm ...

Acurx Pharmaceuticals is undervalued, with promising market potential for its lead antibiotic, ibezapolstat. Find out why ...